首页 > 最新文献

中华消化杂志最新文献

英文 中文
Expression and its significance of long non-coding transcription factor 7 in gastric cancer 长链非编码转录因子7在胃癌中的表达及其意义
Pub Date : 2019-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2019.01.005
Hui Zhang, Jia Xu, Jiangnan Wan, Shan-shan Wang, Yong-Jian Lin, Haifeng Ren, Yeqian Zhang
Objective To explore the expression and clinical pathological significance of long non-coding transcription factor 7 (lncTCF7) in gastric cancer tissues and to investigate the role of lncTCF7 in the invasion and metastasis of gastric cancer by in vitro experimental study. Methods From January to June 2011, one hundred patients with gastric cancer who underwent radical gastrectomy were selected from Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. The expression of lncTCF7 at mRNA level was detected by quantitative real-time polymerase chain reaction (qRT-PCR). The patients were divided into high expression group (50 cases) and low expression group (50 cases) according to the lncTCF7 mRNA expression level. The stable interferenced lncTCF7 cell line (stable interference group) and blank control lncTCF7 cell line (blank control group) were established. Then the relationship between lncTCF7 expression level and clinical pathological characteristics and prognosis was analyzed. The interferenced lncTCF7 cell line was constructed and utilized, and the role of lncTCF7 in the invasion and metastasis of gastric cancer was detected by wound healing, Transwell and Western blotting method. The Chi square test and t test were performed for statistical analysis. The Kaplan-Meier curve was used for survival analysis. Univariate and multivariate analyses were used for screening the independent factors affecting prognosis. Results The results of qRT-PCR showed that the expression levels of lncTCF7 mRNA in high expression group and low expression group were 0.019±0.003 and 0.002±0.001, respectively. The survival rate of high expression group was lower than that of low expression group (46%, 23/50 vs. 72%, 36/50), and the difference was statistically significant (P=0.002 5). The expression level of lncTCF7 was correlated with intravascular tumor thrombus formation, nerve invasion, depth of invasion and lymph node metastasis (χ2=7.862, 7.162, 11.903 and 8.280, all P<0.05). The results of univariate and multivariate analyses showed that the expression level of lncTCF7 was significantly correlated with the depth of invasion (hazard ratio (HR)=4.205, P=0.002; HR=3.125, P=0.018). The results of wound healing assay indicated that lncTCF7 interference could significantly inhibit wound healing ((92.90±1.51)% vs. (12.33±0.67)%, t=48.72, P<0.01). The results of Transwell assay demonstrated that after 24 hours of culture the number of cells passed through the membrane of the chamber of blank control group was higher than that of stable interference group (83.6±12.5 vs. 26.6±4.3), and the difference was statistically significant (t=9.65, P<0.01). The results of Western blotting showed that the expression of E-cadherin, a marker of epithelial origin, of stable interference group was significantly increased compared with that of blank control group (0.32±0.01 vs. 0.76±0.01), however the expression levels of vimentin and N-cadherin, marke
目的探讨长链非编码转录因子7 (lncTCF7)在胃癌组织中的表达及其临床病理意义,并通过体外实验研究lncTCF7在胃癌侵袭转移中的作用。方法选取2011年1 - 6月在上海交通大学医学院附属仁济医院行根治性胃切除术的胃癌患者100例。采用实时荧光定量聚合酶链反应(qRT-PCR)检测lncTCF7 mRNA水平的表达。根据lncTCF7 mRNA表达水平将患者分为高表达组(50例)和低表达组(50例)。建立稳定干扰lncTCF7细胞系(稳定干扰组)和空白对照lncTCF7细胞系(空白对照组)。分析lncTCF7表达水平与临床病理特征及预后的关系。构建并利用受干扰的lncTCF7细胞系,采用创面愈合、Transwell和Western blotting法检测lncTCF7在胃癌侵袭转移中的作用。采用卡方检验和t检验进行统计分析。Kaplan-Meier曲线用于生存分析。采用单因素和多因素分析筛选影响预后的独立因素。结果qRT-PCR结果显示,lncTCF7 mRNA在高表达组和低表达组的表达量分别为0.019±0.003和0.002±0.001。lncTCF7高表达组生存率低于低表达组(46%(23/50)比72%(36/50),差异有统计学意义(P=0.002 5)。lncTCF7表达水平与血管内肿瘤血栓形成、神经浸润、浸润深度、淋巴结转移相关(χ2=7.862、7.162、11.903、8.280,P均<0.05)。单因素和多因素分析结果显示,lncTCF7表达水平与侵袭深度显著相关(风险比(HR)=4.205, P=0.002;HR = 3.125, P = 0.018)。创面愈合实验结果显示,lncTCF7干扰显著抑制创面愈合(92.90±1.51)%比(12.33±0.67)%,t=48.72, P<0.01)。Transwell实验结果显示,培养24 h后,空白对照组通过室膜的细胞数高于稳定干扰组(83.6±12.5比26.6±4.3),差异有统计学意义(t=9.65, P<0.01)。Western blotting结果显示,稳定干扰组上皮源性标志物E-cadherin表达量较空白对照组显著升高(0.32±0.01∶0.76±0.01),而间质源性标志物vimentin、N-cadherin表达量显著降低(0.56±0.01∶0.39±0.01∶0.67±0.01∶0.33±0.01),差异均有统计学意义(t=26.68、10.09、24.14;所有P < 0.05)。结论lncTCF7高表达胃癌患者预后较差。lncTCF7可能通过影响胃癌细胞上皮-间质转化促进胃癌的侵袭转移。关键词:胃肿瘤;长链非编码RNA;侵袭转移;Epithelial-mesenchymal过渡
{"title":"Expression and its significance of long non-coding transcription factor 7 in gastric cancer","authors":"Hui Zhang, Jia Xu, Jiangnan Wan, Shan-shan Wang, Yong-Jian Lin, Haifeng Ren, Yeqian Zhang","doi":"10.3760/CMA.J.ISSN.0254-1432.2019.01.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2019.01.005","url":null,"abstract":"Objective \u0000To explore the expression and clinical pathological significance of long non-coding transcription factor 7 (lncTCF7) in gastric cancer tissues and to investigate the role of lncTCF7 in the invasion and metastasis of gastric cancer by in vitro experimental study. \u0000 \u0000 \u0000Methods \u0000From January to June 2011, one hundred patients with gastric cancer who underwent radical gastrectomy were selected from Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. The expression of lncTCF7 at mRNA level was detected by quantitative real-time polymerase chain reaction (qRT-PCR). The patients were divided into high expression group (50 cases) and low expression group (50 cases) according to the lncTCF7 mRNA expression level. The stable interferenced lncTCF7 cell line (stable interference group) and blank control lncTCF7 cell line (blank control group) were established. Then the relationship between lncTCF7 expression level and clinical pathological characteristics and prognosis was analyzed. The interferenced lncTCF7 cell line was constructed and utilized, and the role of lncTCF7 in the invasion and metastasis of gastric cancer was detected by wound healing, Transwell and Western blotting method. The Chi square test and t test were performed for statistical analysis. The Kaplan-Meier curve was used for survival analysis. Univariate and multivariate analyses were used for screening the independent factors affecting prognosis. \u0000 \u0000 \u0000Results \u0000The results of qRT-PCR showed that the expression levels of lncTCF7 mRNA in high expression group and low expression group were 0.019±0.003 and 0.002±0.001, respectively. The survival rate of high expression group was lower than that of low expression group (46%, 23/50 vs. 72%, 36/50), and the difference was statistically significant (P=0.002 5). The expression level of lncTCF7 was correlated with intravascular tumor thrombus formation, nerve invasion, depth of invasion and lymph node metastasis (χ2=7.862, 7.162, 11.903 and 8.280, all P<0.05). The results of univariate and multivariate analyses showed that the expression level of lncTCF7 was significantly correlated with the depth of invasion (hazard ratio (HR)=4.205, P=0.002; HR=3.125, P=0.018). The results of wound healing assay indicated that lncTCF7 interference could significantly inhibit wound healing ((92.90±1.51)% vs. (12.33±0.67)%, t=48.72, P<0.01). The results of Transwell assay demonstrated that after 24 hours of culture the number of cells passed through the membrane of the chamber of blank control group was higher than that of stable interference group (83.6±12.5 vs. 26.6±4.3), and the difference was statistically significant (t=9.65, P<0.01). The results of Western blotting showed that the expression of E-cadherin, a marker of epithelial origin, of stable interference group was significantly increased compared with that of blank control group (0.32±0.01 vs. 0.76±0.01), however the expression levels of vimentin and N-cadherin, marke","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"49 1","pages":"19-23"},"PeriodicalIF":0.0,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81374503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive function observation and clinical features of 100 cases of elderly patients with non-alcoholic fatty liver disease 100例老年非酒精性脂肪肝患者认知功能观察及临床特点
Pub Date : 2019-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2019.01.008
Jing Xu, Li Yang, Xuan Shi, Dan Wang
Objective To observe the changes of cognitive function, clinical characteristics and hippocampal structure in elderly patients with non-alcoholic fatty liver disease (NAFLD). Methods From December 2014 to June 2016, at Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 169 elderly hospitalized patients who underwent health checkups were enrolled and divided into NAFLD group and non-NAFLD group. The clinical data of two groups were collected, and the Montreal cognitive assessment scale (MoCA) was used for cognitive function assessment. The serum level of soluble transferrin receptor (sTfR) was detected, the liver-spleen ratio was measured and hippocampal proton magnetic resonance spectroscopy (1H-MRS) was performed. T test and linear regression analysis were used for statistical analysis. Results Among the 169 elderly patients, 100 were NAFLD and 69 were non-NAFLD. The body mass index(BMI) and waist-to-hip ratio(WHR)of patients in NAFLD group were (25.9±3.4) kg/m2 and 1.03±0.13, respectively, which were higher than those in non-NAFLD group ((24.2±3.7) kg/m2 and 0.95±0.06), and the differences were statistically significant (t=-2.714 and -3.605, both P<0.01). MoCA score of the patients in NAFLD group was 20.1±5.8, which was lower than that in non-NAFLD group (22.1±4.4), and the difference was statistically significant(t=2.154, P=0.033). The serum sTfR level and liver-spleen computed tomography(CT) ratio of NAFLD group were (8.78±4.31) mg/L and 0.97±0.12, respectively, which were lower than those of non-NAFLD group ((12.66±3.93) mg/L and 1.19±0.15), and the differences were statistically significant(t=3.765 and 6.142, both P<0.01). The CT ratio of liver to spleen (β=7.597, 95% confidence interval(CI): 2.938 to 12.935) and sTfR (β= 0.552, 95%CI: 0.304 to 0.787) were positively correlated with cognitive function in elderly patients (both P<0.01). The height of right hippocampus of NAFLD group was (0.410±0.074) mm, which was lower than that of non-NAFLD group ((0.453±0.086) mm), and the difference was statistically significant (t=2.078, P=0.042). Conclusion Cognitive impairment in elderly NAFLD patients is closely related to iron load and liver fat. Key words: Cognition; Non-alcoholic fatty liver disease; Soluble transferrin receptor; Proton magnetic resonance spectroscopy
目的观察老年非酒精性脂肪性肝病(NAFLD)患者认知功能、临床特征及海马结构的变化。方法选取2014年12月至2016年6月南京大学医学院附属医院南京鼓楼医院老年病科接受健康检查的住院老年患者169例,分为NAFLD组和非NAFLD组。收集两组患者的临床资料,采用蒙特利尔认知评估量表(MoCA)进行认知功能评估。检测血清可溶性转铁蛋白受体(sTfR)水平,测定肝脾比,海马质子磁共振波谱(1H-MRS)。采用T检验和线性回归分析进行统计分析。结果169例老年患者中,NAFLD 100例,非NAFLD 69例。NAFLD组患者体重指数(BMI)和腰臀比(WHR)分别为(25.9±3.4)kg/m2和1.03±0.13,高于非NAFLD组((24.2±3.7)kg/m2和0.95±0.06),差异有统计学意义(t=-2.714和-3.605,P均<0.01)。NAFLD组患者MoCA评分为20.1±5.8分,低于非NAFLD组(22.1±4.4分),差异有统计学意义(t=2.154, P=0.033)。NAFLD组血清sTfR水平和肝脾CT比值分别为(8.78±4.31)mg/L和(0.97±0.12)mg/L低于非NAFLD组((12.66±3.93)mg/L和(1.19±0.15)mg/L,差异有统计学意义(t=3.765、6.142,P均<0.01)。肝脾CT比值(β=7.597, 95%可信区间(CI) 2.938 ~ 12.935)和sTfR (β= 0.552, 95%CI: 0.304 ~ 0.787)与老年患者认知功能呈正相关(P<0.01)。NAFLD组右侧海马高度为(0.410±0.074)mm,低于非NAFLD组(0.453±0.086)mm,差异有统计学意义(t=2.078, P=0.042)。结论老年NAFLD患者认知功能障碍与铁负荷和肝脂肪密切相关。关键词:认知;非酒精性脂肪肝;可溶性转铁蛋白受体;质子磁共振波谱学
{"title":"Cognitive function observation and clinical features of 100 cases of elderly patients with non-alcoholic fatty liver disease","authors":"Jing Xu, Li Yang, Xuan Shi, Dan Wang","doi":"10.3760/CMA.J.ISSN.0254-1432.2019.01.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2019.01.008","url":null,"abstract":"Objective \u0000To observe the changes of cognitive function, clinical characteristics and hippocampal structure in elderly patients with non-alcoholic fatty liver disease (NAFLD). \u0000 \u0000 \u0000Methods \u0000From December 2014 to June 2016, at Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 169 elderly hospitalized patients who underwent health checkups were enrolled and divided into NAFLD group and non-NAFLD group. The clinical data of two groups were collected, and the Montreal cognitive assessment scale (MoCA) was used for cognitive function assessment. The serum level of soluble transferrin receptor (sTfR) was detected, the liver-spleen ratio was measured and hippocampal proton magnetic resonance spectroscopy (1H-MRS) was performed. T test and linear regression analysis were used for statistical analysis. \u0000 \u0000 \u0000Results \u0000Among the 169 elderly patients, 100 were NAFLD and 69 were non-NAFLD. The body mass index(BMI) and waist-to-hip ratio(WHR)of patients in NAFLD group were (25.9±3.4) kg/m2 and 1.03±0.13, respectively, which were higher than those in non-NAFLD group ((24.2±3.7) kg/m2 and 0.95±0.06), and the differences were statistically significant (t=-2.714 and -3.605, both P<0.01). MoCA score of the patients in NAFLD group was 20.1±5.8, which was lower than that in non-NAFLD group (22.1±4.4), and the difference was statistically significant(t=2.154, P=0.033). The serum sTfR level and liver-spleen computed tomography(CT) ratio of NAFLD group were (8.78±4.31) mg/L and 0.97±0.12, respectively, which were lower than those of non-NAFLD group ((12.66±3.93) mg/L and 1.19±0.15), and the differences were statistically significant(t=3.765 and 6.142, both P<0.01). The CT ratio of liver to spleen (β=7.597, 95% confidence interval(CI): 2.938 to 12.935) and sTfR (β= 0.552, 95%CI: 0.304 to 0.787) were positively correlated with cognitive function in elderly patients (both P<0.01). The height of right hippocampus of NAFLD group was (0.410±0.074) mm, which was lower than that of non-NAFLD group ((0.453±0.086) mm), and the difference was statistically significant (t=2.078, P=0.042). \u0000 \u0000 \u0000Conclusion \u0000Cognitive impairment in elderly NAFLD patients is closely related to iron load and liver fat. \u0000 \u0000 \u0000Key words: \u0000Cognition; Non-alcoholic fatty liver disease; Soluble transferrin receptor; Proton magnetic resonance spectroscopy","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"1 1","pages":"35-39"},"PeriodicalIF":0.0,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76310341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics of 326 cases of erosive esophagitis in healthy population undergoing health checkup in Eastern Zhejiang Province 浙东地区体检健康人群糜烂性食管炎326例临床特点分析
Pub Date : 2019-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2019.01.002
H. Ren, Dawei Chen, N. Dai
Objective To explore the incidence of asymptomatic erosive esophagitis (AEE) and clinical characteristics of symptoms of erosive esophagitis in healthy population undergoing health check-up. Methods From January 2012 to December 2015, at Ningbo Medical Treatment Center Lihuili Eastern Hospital, a total of 3 052 healthy people receiving routine health checkup and underwent gastroendoscopy were retrospectively analyzed. The demographic characteristics, endoscopic findings, reflux-related symptoms, metabolic syndrome and biochemical parameters were analyzed in AEE and symptomatic erosive esophagitis (SEE) patients. T test and Chi square test were performed for univariate analysis, and multivariate logistic regression analysis was used to compare differences between AEE and SEE patients. Results There were 326 cases of erosive esophagitis, and the incidence rate was 10.7% (326/3 052). Among them, the incidence rate of AEE was 4.9% (151/3 052), which accounted for 46.3% (151/326) of erosive esophagitis; and the incidence rate of SEE was 5.7% (175/3 052), and accounted for 53.7% (175/326) of erosive esophagitis. About 98.2%(320/326) of the patients were diagnosed with mild esophagitis (Los Angeles grade A or B). The results of univariate analysis indicated that, compared with AEE group, there were more smokers (31.8%, 48/151 vs. 45.7%, 80/175) and more drinkers (27.8%, 42/151 vs. 41.7%, 73/175), and higher body mass index (BMI) ((23.95±2.32) kg/m2 vs. (24.53±2.19) kg/m2) were in SEE group, and the differences were statistically significant (χ2=6.592 and 6.859, t=-2.351; all P 0.05). The results of multivariate logistic regression analysis indicated that smoking (odds ratio (OR)=1.67, 95% confidence interval (CI) 1.05 to 2.65, P=0.030), alcohol drinking (OR=1.69, 95%CI 1.05 to 2.72, P=0.030) and high BMI (OR=1.11, 95%CI 1.00 to 1.23, P=0.044) were the independent risk factors of gastroesophageal reflux symptoms in patients with erosive esophagitis. Conclusions AEE is common in Chinese population, and the incidence is similar to SEE. Smoking, alcohol drinking and high BMI are the risk factors of reflux symptom in patients with erosive esophagitis. Key words: Endoscopy; Risk factors; Asymptomatic erosive esophagitis; Gastroesophageal reflux disease symptoms
目的探讨无症状糜烂性食管炎(AEE)在健康体检人群中的发病率及糜烂性食管炎症状的临床特点。方法回顾性分析2012年1月至2015年12月宁波市医疗中心丽丽丽东方医院例行体检并行胃镜检查的健康人群3 052例。分析AEE和症状性糜烂性食管炎(SEE)患者的人口学特征、内镜检查结果、反流相关症状、代谢综合征和生化参数。单因素分析采用T检验和卡方检验,多因素logistic回归分析比较AEE与SEE患者的差异。结果糜烂性食管炎326例,发生率为10.7%(326/3 052)。其中,AEE的发病率为4.9%(153 /3 052),占糜烂性食管炎的46.3% (151/326);SEE的发生率为5.7%(175/3 052),占糜烂性食管炎的53.7%(175/326)。约98.2%(320/326)的患者被诊断为轻度食管炎(洛杉矶A级或B级)。单因素分析结果显示,与AEE组相比,SEE组吸烟者较多(31.8%,48/151比45.7%,80/175),饮酒者较多(27.8%,42/151比41.7%,73/175),体重指数(BMI)较高((23.95±2.32)kg/m2比(24.53±2.19)kg/m2),差异有统计学意义(χ2=6.592和6.859,t=-2.351;P < 0.05)。多因素logistic回归分析结果显示,吸烟(优势比(OR)=1.67, 95%可信区间(CI) 1.05 ~ 2.65, P=0.030)、饮酒(OR=1.69, 95%CI 1.05 ~ 2.72, P=0.030)和高BMI (OR=1.11, 95%CI 1.00 ~ 1.23, P=0.044)是糜烂性食管炎患者胃食管反流症状的独立危险因素。结论AEE在中国人群中较为常见,发病率与SEE相似。吸烟、饮酒和高BMI是糜烂性食管炎患者反流症状的危险因素。关键词:内窥镜检查;风险因素;无症状糜烂性食管炎;胃食管反流病的症状
{"title":"Clinical characteristics of 326 cases of erosive esophagitis in healthy population undergoing health checkup in Eastern Zhejiang Province","authors":"H. Ren, Dawei Chen, N. Dai","doi":"10.3760/CMA.J.ISSN.0254-1432.2019.01.002","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2019.01.002","url":null,"abstract":"Objective \u0000To explore the incidence of asymptomatic erosive esophagitis (AEE) and clinical characteristics of symptoms of erosive esophagitis in healthy population undergoing health check-up. \u0000 \u0000 \u0000Methods \u0000From January 2012 to December 2015, at Ningbo Medical Treatment Center Lihuili Eastern Hospital, a total of 3 052 healthy people receiving routine health checkup and underwent gastroendoscopy were retrospectively analyzed. The demographic characteristics, endoscopic findings, reflux-related symptoms, metabolic syndrome and biochemical parameters were analyzed in AEE and symptomatic erosive esophagitis (SEE) patients. T test and Chi square test were performed for univariate analysis, and multivariate logistic regression analysis was used to compare differences between AEE and SEE patients. \u0000 \u0000 \u0000Results \u0000There were 326 cases of erosive esophagitis, and the incidence rate was 10.7% (326/3 052). Among them, the incidence rate of AEE was 4.9% (151/3 052), which accounted for 46.3% (151/326) of erosive esophagitis; and the incidence rate of SEE was 5.7% (175/3 052), and accounted for 53.7% (175/326) of erosive esophagitis. About 98.2%(320/326) of the patients were diagnosed with mild esophagitis (Los Angeles grade A or B). The results of univariate analysis indicated that, compared with AEE group, there were more smokers (31.8%, 48/151 vs. 45.7%, 80/175) and more drinkers (27.8%, 42/151 vs. 41.7%, 73/175), and higher body mass index (BMI) ((23.95±2.32) kg/m2 vs. (24.53±2.19) kg/m2) were in SEE group, and the differences were statistically significant (χ2=6.592 and 6.859, t=-2.351; all P 0.05). The results of multivariate logistic regression analysis indicated that smoking (odds ratio (OR)=1.67, 95% confidence interval (CI) 1.05 to 2.65, P=0.030), alcohol drinking (OR=1.69, 95%CI 1.05 to 2.72, P=0.030) and high BMI (OR=1.11, 95%CI 1.00 to 1.23, P=0.044) were the independent risk factors of gastroesophageal reflux symptoms in patients with erosive esophagitis. \u0000 \u0000 \u0000Conclusions \u0000AEE is common in Chinese population, and the incidence is similar to SEE. Smoking, alcohol drinking and high BMI are the risk factors of reflux symptom in patients with erosive esophagitis. \u0000 \u0000 \u0000Key words: \u0000Endoscopy; Risk factors; Asymptomatic erosive esophagitis; Gastroesophageal reflux disease symptoms","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"19 1","pages":"2-6"},"PeriodicalIF":0.0,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87459530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammatory bowel disease with thrombosis: a single center retrospective study 炎症性肠病伴血栓形成:单中心回顾性研究
Pub Date : 2019-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2019.01.007
L. Jin, Wei Juan, Chen Chunyan, Z. Li, Chen Zhijian, Wu Lin, Wu Xingjiang, Wang Fang-yu, Liu Jiong
Objective To analyze the clinical features and clinical significance of patients with inflammatory bowel disease (IBD) complicated by thrombosis. Methods From March 14th, 2001 to February sixth 2017, at Nanjing General Hospital of Nanjing Military Command, 27 IBD patients with thrombosis diagnosed by clinical symptoms, endoscopy, imaging and pathology were enrolled. During the same period, 81 gender and age matched IBD patients without thrombosis were included in the control group. The basic data, information of IBD diagnosis and treatment and thrombotic events of patients were collected and analyzed. T-test and Chi-square test were performed for statistical analysis. Binary logistics regression was used for risk factors analysis. Results The mean age of diagnosis of IBD patients with thrombosis was (44.8±15.8) years, which was higher than that of the IBD patients of control group ((36.0±14.4) years), and the difference was statistically significant (t=2.69, P=0.008). Among 27 IBD patients with thrombosis, arterial thrombosis was 51.9%(14/27), deep venous thrombosis of the lower extremity veins was 29.6%(8/27), portal venous system involved was 11.1% (3/27), pulmonary embolism was 3.7%(1/27) and disseminated intravascular coagulation accounted for 7.4%(2/27). Nine patients (33.3%, 9/27) underwent surgery six months before the diagnosis of thrombosis. The results of binary logistic regression indicated that the age of diagnosis and vascular catheterization were independent risk factors for thrombosis in IBD patients (odds ratio (OR)=1.04, 95%confidence interval (CI)1.01 to 1.07, P=0.01; OR=5.64, 95%CI 1.39 to 22.96, P=0.02). After medicine treatment or surgery, 81.5%(22/27) of the patients improved, 9.1%(2/22) were worse and 13.6%(3/22) died. Conclusion Screening and prevention of thrombosis should be paid attention in IBD patients with a history of vascular catheterization, at active phase and older age when diagnosed. Key words: Inflammatory bowel diseases; Venous thrombosis; Risk factors
目的分析炎症性肠病(IBD)合并血栓形成的临床特点及临床意义。方法选取2001年3月14日至2017年2月6日南京军区南京总医院经临床症状、内镜、影像学及病理诊断为血栓形成的IBD患者27例。同期选取81例性别和年龄匹配且无血栓形成的IBD患者作为对照组。收集并分析IBD患者的基本资料、诊治信息及血栓事件。采用t检验和卡方检验进行统计学分析。危险因素分析采用二元logistic回归。结果IBD合并血栓患者的平均诊断年龄为(44.8±15.8)岁,高于对照组IBD患者的平均诊断年龄(36.0±14.4)岁,差异有统计学意义(t=2.69, P=0.008)。27例IBD血栓形成患者中,动脉血栓形成占51.9%(14/27),下肢静脉深静脉血栓形成占29.6%(8/27),门静脉受累占11.1%(3/27),肺栓塞占3.7%(1/27),弥散性血管内凝血占7.4%(2/27)。9例患者(33.3%,9/27)在诊断血栓形成前6个月接受手术治疗。二元logistic回归结果显示,诊断年龄和血管插管是IBD患者血栓形成的独立危险因素(优势比(OR)=1.04, 95%可信区间(CI)1.01 ~ 1.07, P=0.01;OR=5.64, 95%CI 1.39 ~ 22.96, P=0.02)。经药物或手术治疗后,81.5%(22/27)患者好转,9.1%(2/22)患者恶化,13.6%(3/22)患者死亡。结论有血管置管史的IBD患者、活动期患者和确诊时年龄较大的IBD患者应重视血栓的筛查和预防。关键词:炎症性肠病;静脉血栓形成;风险因素
{"title":"Inflammatory bowel disease with thrombosis: a single center retrospective study","authors":"L. Jin, Wei Juan, Chen Chunyan, Z. Li, Chen Zhijian, Wu Lin, Wu Xingjiang, Wang Fang-yu, Liu Jiong","doi":"10.3760/CMA.J.ISSN.0254-1432.2019.01.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2019.01.007","url":null,"abstract":"Objective \u0000To analyze the clinical features and clinical significance of patients with inflammatory bowel disease (IBD) complicated by thrombosis. \u0000 \u0000 \u0000Methods \u0000From March 14th, 2001 to February sixth 2017, at Nanjing General Hospital of Nanjing Military Command, 27 IBD patients with thrombosis diagnosed by clinical symptoms, endoscopy, imaging and pathology were enrolled. During the same period, 81 gender and age matched IBD patients without thrombosis were included in the control group. The basic data, information of IBD diagnosis and treatment and thrombotic events of patients were collected and analyzed. T-test and Chi-square test were performed for statistical analysis. Binary logistics regression was used for risk factors analysis. \u0000 \u0000 \u0000Results \u0000The mean age of diagnosis of IBD patients with thrombosis was (44.8±15.8) years, which was higher than that of the IBD patients of control group ((36.0±14.4) years), and the difference was statistically significant (t=2.69, P=0.008). Among 27 IBD patients with thrombosis, arterial thrombosis was 51.9%(14/27), deep venous thrombosis of the lower extremity veins was 29.6%(8/27), portal venous system involved was 11.1% (3/27), pulmonary embolism was 3.7%(1/27) and disseminated intravascular coagulation accounted for 7.4%(2/27). Nine patients (33.3%, 9/27) underwent surgery six months before the diagnosis of thrombosis. The results of binary logistic regression indicated that the age of diagnosis and vascular catheterization were independent risk factors for thrombosis in IBD patients (odds ratio (OR)=1.04, 95%confidence interval (CI)1.01 to 1.07, P=0.01; OR=5.64, 95%CI 1.39 to 22.96, P=0.02). After medicine treatment or surgery, 81.5%(22/27) of the patients improved, 9.1%(2/22) were worse and 13.6%(3/22) died. \u0000 \u0000 \u0000Conclusion \u0000Screening and prevention of thrombosis should be paid attention in IBD patients with a history of vascular catheterization, at active phase and older age when diagnosed. \u0000 \u0000 \u0000Key words: \u0000Inflammatory bowel diseases; Venous thrombosis; Risk factors","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"145 12 1","pages":"31-34"},"PeriodicalIF":0.0,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84863980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical features and esophageal motility characteristics of patients with esophagogastric junction outflow obstruction 食管胃交界流出性梗阻的临床特点及食管运动特征
Pub Date : 2019-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2019.01.003
Xia Liu, Hong Wang, Ling-ting Wang, Qianshu Liu
Objective To analyze the clinical features and esophageal motility characteristics of patients with esophagogastric junction outflow obstruction (EGJOO). Methods From January 2015 to January 2018, at Affiliated Hospital of Zunyi Medical College, the clinical data of 663 outpatients with various gastrointestinal symptoms were collected. Gastroscopy and esophageal high resolution manometry (HRM) were performed to exclude gastrointestinal organic lesions. The 120 patients were divided into EGJOO group (71 cases) and non-EGJOO group (49 cases). Furthermore, according to integrated relaxation pressure (IRP) the 71 EGJOO patients were divided into mild group (41 cases), moderate group (20 cases) and severe group (10 cases). Independent sample t test and one-way analysis of variance were performed for statistical analysis. Results Among 71 EGJOO patients, 43.7% (31/71) showed post sternal heartburn or acid regurgitation, 32.4% (23/71) showed obstruction or dysphagia, 21.1% (15/71) showed chest pain, 21.1% (15/71) showed other atypical symptoms such as hiccups and bloating, and 5.6% (4/71) showed upper abdominal pain. The IRP, lower esophageal sphincter (LES) length, LES resting pressure and intrabolus pressure (IBP) of the EGJOO group were higher than those of the non-EGJOO group ((18.24±3.07) mmHg (1 mmHg=0.133 kPa) vs. (10.92±2.37) mmHg, (3.47±0.85) cm vs. (3.11±0.80) cm, (32.33±9.11) mmHg vs. (21.31±6.55) mmHg, (6.22±3.74) mmHg vs. (4.69±2.68) mmHg), and the differences were statistically significant (t=-13.947, -2.303, -7.706 and -2.626; all P<0.05). The LES relaxation rate and distal contractile integral (DCI) of the EGJOO group were lower than those of the non-EGJOO group ((44.03±9.86)% vs. (53.86±11.33)%, (1 410.13±794.23) mmHg·s·cm vs. (1 741.86±894.16) mmHg·s·cm), and the differences were statistically significant (t=5.046 and 2.136, both P<0.05). The LES resting pressure of the mild group was higher than that of the moderate group ((30.76±9.23) mmHg vs. (29.69±5.87) mmHg); the LES resting pressure of the moderate group was lower than that of the severe group ((29.69±5.87) mmHg vs. (42.02±9.23) mmHg); and the differences were statistically significant (both Tamhane test, P=0.012 and 0.011). The IBP of the mild group was lower than that of the moderate group and the severe group ((5.16±3.41) mmHg vs. (8.02±2.58) mmHg and (7.46±3.48) mmHg), and the differences were statistically significant (both least-significant difference test, both P<0.05). The DCI of the mild group was lower than that of the moderate group ((1 241.41±606.12) mmHg·s·cm vs. (1 438.55±644.74) mmHg·s·cm), and the difference was statistically significant (Tamhane test, P=0.011). Conclusions Heartburn, acid reflux and dysphagia are common clinical symptoms in EGJOO patients. The weaker the peristalsis of the esophageal body of EGJOO patients, the more obvious of dysphagia. Increased IBP is an indirect manifestation of esophagogastric junction relaxation disorder
目的分析食管胃交界流出性梗阻(EGJOO)患者的临床特点及食管运动特征。方法收集2015年1月至2018年1月遵义医学院附属医院663例出现各种胃肠道症状的门诊患者的临床资料。通过胃镜检查和食管高分辨率测压(HRM)排除胃肠道器质性病变。120例患者分为EGJOO组(71例)和非EGJOO组(49例)。根据综合松弛压(IRP)将71例EGJOO患者分为轻度组(41例)、中度组(20例)和重度组(10例)。采用独立样本t检验和单因素方差分析进行统计分析。结果71例EGJOO患者中,43.7%(31/71)表现为胸骨后烧心或胃酸反流,32.4%(23/71)表现为梗阻或吞咽困难,21.1%(15/71)表现为胸痛,21.1%(15/71)表现为呃逆、腹胀等其他不典型症状,5.6%(4/71)表现为上腹痛。EGJOO组的IRP、食管下括括肌(LES)长度、LES静息压和肠内压(IBP)均高于非EGJOO组((18.24±3.07)mmHg (1 mmHg=0.133 kPa)比(10.92±2.37)mmHg,(3.47±0.85)cm比(3.11±0.80)cm,(32.33±9.11)mmHg比(21.31±6.55)mmHg,(6.22±3.74)mmHg比(4.69±2.68)mmHg),差异均有统计学意义(t=-13.947, -2.303, -7.706和-2.626;所有P < 0.05)。EGJOO组的LES松弛率和远端收缩积分(DCI)低于非EGJOO组((44.03±9.86)% vs(53.86±11.33)%,(1 410.13±794.23)mmHg·s·cm vs(1 741.86±894.16)mmHg·s·cm),差异均有统计学意义(t=5.046和2.136,P均<0.05)。轻度组LES静息压高于中度组((30.76±9.23)mmHg vs(29.69±5.87)mmHg);中度组LES静息压低于重度组((29.69±5.87)mmHg vs(42.02±9.23)mmHg);差异有统计学意义(Tamhane检验,P=0.012和0.011)。轻度组IBP低于中度组和重度组((5.16±3.41)mmHg vs(8.02±2.58)mmHg和(7.46±3.48)mmHg),差异均有统计学意义(均采用最小显著性差异检验,P<0.05)。轻度组DCI低于中度组((1 241.41±606.12)mmHg·s·cm vs(1 438.55±644.74)mmHg·s·cm),差异有统计学意义(Tamhane检验,P=0.011)。结论胃灼热、胃酸反流和吞咽困难是EGJOO患者常见的临床症状。EGJOO患者食管体蠕动越弱,吞咽困难越明显。IBP升高是食管胃交界松弛障碍的间接表现。关键词:食管胃交界流出梗阻;食管蠕动;临床特点;高分辨率测压法
{"title":"Clinical features and esophageal motility characteristics of patients with esophagogastric junction outflow obstruction","authors":"Xia Liu, Hong Wang, Ling-ting Wang, Qianshu Liu","doi":"10.3760/CMA.J.ISSN.0254-1432.2019.01.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2019.01.003","url":null,"abstract":"Objective \u0000To analyze the clinical features and esophageal motility characteristics of patients with esophagogastric junction outflow obstruction (EGJOO). \u0000 \u0000 \u0000Methods \u0000From January 2015 to January 2018, at Affiliated Hospital of Zunyi Medical College, the clinical data of 663 outpatients with various gastrointestinal symptoms were collected. Gastroscopy and esophageal high resolution manometry (HRM) were performed to exclude gastrointestinal organic lesions. The 120 patients were divided into EGJOO group (71 cases) and non-EGJOO group (49 cases). Furthermore, according to integrated relaxation pressure (IRP) the 71 EGJOO patients were divided into mild group (41 cases), moderate group (20 cases) and severe group (10 cases). Independent sample t test and one-way analysis of variance were performed for statistical analysis. \u0000 \u0000 \u0000Results \u0000Among 71 EGJOO patients, 43.7% (31/71) showed post sternal heartburn or acid regurgitation, 32.4% (23/71) showed obstruction or dysphagia, 21.1% (15/71) showed chest pain, 21.1% (15/71) showed other atypical symptoms such as hiccups and bloating, and 5.6% (4/71) showed upper abdominal pain. The IRP, lower esophageal sphincter (LES) length, LES resting pressure and intrabolus pressure (IBP) of the EGJOO group were higher than those of the non-EGJOO group ((18.24±3.07) mmHg (1 mmHg=0.133 kPa) vs. (10.92±2.37) mmHg, (3.47±0.85) cm vs. (3.11±0.80) cm, (32.33±9.11) mmHg vs. (21.31±6.55) mmHg, (6.22±3.74) mmHg vs. (4.69±2.68) mmHg), and the differences were statistically significant (t=-13.947, -2.303, -7.706 and -2.626; all P<0.05). The LES relaxation rate and distal contractile integral (DCI) of the EGJOO group were lower than those of the non-EGJOO group ((44.03±9.86)% vs. (53.86±11.33)%, (1 410.13±794.23) mmHg·s·cm vs. (1 741.86±894.16) mmHg·s·cm), and the differences were statistically significant (t=5.046 and 2.136, both P<0.05). The LES resting pressure of the mild group was higher than that of the moderate group ((30.76±9.23) mmHg vs. (29.69±5.87) mmHg); the LES resting pressure of the moderate group was lower than that of the severe group ((29.69±5.87) mmHg vs. (42.02±9.23) mmHg); and the differences were statistically significant (both Tamhane test, P=0.012 and 0.011). The IBP of the mild group was lower than that of the moderate group and the severe group ((5.16±3.41) mmHg vs. (8.02±2.58) mmHg and (7.46±3.48) mmHg), and the differences were statistically significant (both least-significant difference test, both P<0.05). The DCI of the mild group was lower than that of the moderate group ((1 241.41±606.12) mmHg·s·cm vs. (1 438.55±644.74) mmHg·s·cm), and the difference was statistically significant (Tamhane test, P=0.011). \u0000 \u0000 \u0000Conclusions \u0000Heartburn, acid reflux and dysphagia are common clinical symptoms in EGJOO patients. The weaker the peristalsis of the esophageal body of EGJOO patients, the more obvious of dysphagia. Increased IBP is an indirect manifestation of esophagogastric junction relaxation disorder","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"101 1","pages":"7-11"},"PeriodicalIF":0.0,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85461641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Association of decoy receptors and osteoprotegerin gene polymorphisms with susceptibility and clinical phenotypes of Crohn′s disease 诱饵受体和骨保护素基因多态性与克罗恩病的易感性和临床表型的关联
Pub Date : 2019-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2019.01.006
X. Shao, D. Lin, Liang Sun, Q. Lin, Shijie Ying, Baoping Yu
Objective To investigate the correlation between decoy receptor (DcR)1, DcR2, osteoprotegerin (OPG) gene polymorphisms and susceptibility of Crohn′s disease (CD) in Han population in Zhejiang province. Methods From April 2008 to July 2017, at the Department of Gastroenterology of The Second Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of Wenzhou Medical University, Central Hospital of Wenzhou and Renmin Hospital of Wenzhou, 285 patients diagnosed as having CD were enrolled, and during the same period 572 healthy individuals who received health checkup at the Second Affiliated Hospital of Wenzhou Medical University were collected as healthy control. The single nucleotide polymorphism (SNP) of DcR1 (rs12549481), DcR2 (rs1133782) and OPG (rs3102735) were examined by SNaPshot technique. An unconditional logistic regression analysis was performed to analyze the differences in each SNP mutation alleles and genotype frequencies between CD group and control group. Furthermore, their correlation with clinicopathological features of CD and the efficacy of corticosteroid and infliximab was also evaluated. Results The frequencies of mutant allele A and genotype GA+ AA of DcR2 (rs1133782) of CD group were 11.93% (68/570) and 22.81% (65/285), respectively, which were higher than those of healthy control group (8.22%, 94/1 144; and 15.91%, 91/572; odds ratio (OR)=1.513, 95% confidence interval (CI) 1.088 to 2.104, P=0.013; OR=1.562, 95%CI 1.094 to 2.230, P=0.014). However there was no statistically significant difference in the mutant allele and genotype frequencies of DcR1 (rs12549481) and OPG (rs3102735) between two groups (all P>0.05). The frequencies of mutant allele C and genotype TC+ CC of DcR1 (rs12549481) in patients with stricturing CD were 13.89% (25/180) and 27.78% (25/90), respectively, which were lower than those of patients with non-stricturing, non-penetrating CD (27.68%, 62/224 and 48.21%, 54/112), and the differences were statistically significant (OR=0.421, 95%CI 0.252 to 0.705, P=0.001; OR=0.413, 95%CI 0.229 to 0.747, P=0.003). Besides, the frequencies of mutant allele A and genotypes GA+ AA of DcR2 in patients with penetrating CD were 7.23% (12/166) and 13.25% (11/83), which were lower than those of patients with non-stricturing, non-penetrating CD (15.62%, 35/224 and 30.36%, 34/112), and the differences were statistically significant (OR=0.407, 95%CI 0.205 to 0.809, P=0.009; OR=0.350, 95%CI 0.165 to 0.743, P=0.005). In addition, there was no statistically significant difference in the frequencies of mutant allele and genotypes of OPG (rs3102735) among subtypes of CD with different features (all P>0.012 5). Moreover, the DcR1 (rs12549481), DcR2 (rs1133782) and OPG (rs3102735) polymorphisms were not correlated with the efficacy of corticosteroid and infliximab (all P>0.05). Conclusions DcR1 (rs12549481) mutation may be correlated with stricturing CD. DcR2 (rs1133782) mutation may be corre
目的探讨浙江省汉族人群诱饵受体(dcr1)、DcR2、骨保护素(OPG)基因多态性与克罗恩病(CD)易感性的相关性。方法2008年4月至2017年7月,在温州医科大学第二附属医院、温州医科大学第一附属医院、温州市中心医院和温州市人民医院消化内科共纳入确诊为乳糜泻的285例患者,并收集同期在温州医科大学第二附属医院进行健康体检的健康个体572例作为健康对照。采用SNaPshot技术检测DcR1 (rs12549481)、DcR2 (rs1133782)和OPG (rs3102735)的单核苷酸多态性(SNP)。采用无条件logistic回归分析CD组与对照组各SNP突变等位基因及基因型频率的差异。此外,还评估了它们与CD的临床病理特征以及皮质类固醇和英夫利昔单抗的疗效的相关性。结果CD组DcR2 (rs1133782)突变等位基因A和基因型GA+ AA的频率分别为11.93%(68/570)和22.81%(65/285),高于健康对照组(8.22%,94/1 144);15.91%, 91/572;优势比(OR)=1.513, 95%可信区间(CI) 1.088 ~ 2.104, P=0.013;OR=1.562, 95%CI 1.094 ~ 2.230, P=0.014)。两组间DcR1 (rs12549481)和OPG (rs3102735)突变等位基因及基因型频率比较,差异均无统计学意义(P>0.05)。狭窄性CD患者DcR1 (rs12549481)突变等位基因C和TC+ CC的频率分别为13.89%(25/180)和27.78%(25/90),低于非狭窄性、非穿透性CD患者(27.68%,62/224和48.21%,54/112),差异有统计学意义(OR=0.421, 95%CI 0.252 ~ 0.705, P=0.001;OR=0.413, 95%CI 0.229 ~ 0.747, P=0.003)。穿透性CD患者DcR2突变等位基因A和基因型GA+ AA的频率分别为7.23%(12/166)和13.25%(11/83),低于非狭窄性、非穿透性CD患者的频率(15.62%(35/224)和30.36%(34/112),差异有统计学意义(OR=0.407, 95%CI 0.205 ~ 0.809, P=0.009;OR=0.350, 95%CI 0.165 ~ 0.743, P=0.005)。不同特征CD亚型中OPG (rs3102735)突变等位基因频率和基因型差异无统计学意义(P>0.012 5), DcR1 (rs12549481)、DcR2 (rs1133782)和OPG (rs3102735)多态性与皮质类固醇和英夫利昔单抗的疗效无相关性(P>0.05)。结论DcR1 (rs12549481)突变可能与狭窄性CD相关,DcR2 (rs1133782)突变可能与CD相关,尤其是与穿透性CD相关,而OPG (rs3102735)基因多态性与CD易感性风险无关。上述基因SNP可能与皮质类固醇和英夫利昔单抗的疗效无关。关键词:克罗恩病;多态性,单核苷酸;诱饵受体;Osteoprotegerin
{"title":"Association of decoy receptors and osteoprotegerin gene polymorphisms with susceptibility and clinical phenotypes of Crohn′s disease","authors":"X. Shao, D. Lin, Liang Sun, Q. Lin, Shijie Ying, Baoping Yu","doi":"10.3760/CMA.J.ISSN.0254-1432.2019.01.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2019.01.006","url":null,"abstract":"Objective \u0000To investigate the correlation between decoy receptor (DcR)1, DcR2, osteoprotegerin (OPG) gene polymorphisms and susceptibility of Crohn′s disease (CD) in Han population in Zhejiang province. \u0000 \u0000 \u0000Methods \u0000From April 2008 to July 2017, at the Department of Gastroenterology of The Second Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of Wenzhou Medical University, Central Hospital of Wenzhou and Renmin Hospital of Wenzhou, 285 patients diagnosed as having CD were enrolled, and during the same period 572 healthy individuals who received health checkup at the Second Affiliated Hospital of Wenzhou Medical University were collected as healthy control. The single nucleotide polymorphism (SNP) of DcR1 (rs12549481), DcR2 (rs1133782) and OPG (rs3102735) were examined by SNaPshot technique. An unconditional logistic regression analysis was performed to analyze the differences in each SNP mutation alleles and genotype frequencies between CD group and control group. Furthermore, their correlation with clinicopathological features of CD and the efficacy of corticosteroid and infliximab was also evaluated. \u0000 \u0000 \u0000Results \u0000The frequencies of mutant allele A and genotype GA+ AA of DcR2 (rs1133782) of CD group were 11.93% (68/570) and 22.81% (65/285), respectively, which were higher than those of healthy control group (8.22%, 94/1 144; and 15.91%, 91/572; odds ratio (OR)=1.513, 95% confidence interval (CI) 1.088 to 2.104, P=0.013; OR=1.562, 95%CI 1.094 to 2.230, P=0.014). However there was no statistically significant difference in the mutant allele and genotype frequencies of DcR1 (rs12549481) and OPG (rs3102735) between two groups (all P>0.05). The frequencies of mutant allele C and genotype TC+ CC of DcR1 (rs12549481) in patients with stricturing CD were 13.89% (25/180) and 27.78% (25/90), respectively, which were lower than those of patients with non-stricturing, non-penetrating CD (27.68%, 62/224 and 48.21%, 54/112), and the differences were statistically significant (OR=0.421, 95%CI 0.252 to 0.705, P=0.001; OR=0.413, 95%CI 0.229 to 0.747, P=0.003). Besides, the frequencies of mutant allele A and genotypes GA+ AA of DcR2 in patients with penetrating CD were 7.23% (12/166) and 13.25% (11/83), which were lower than those of patients with non-stricturing, non-penetrating CD (15.62%, 35/224 and 30.36%, 34/112), and the differences were statistically significant (OR=0.407, 95%CI 0.205 to 0.809, P=0.009; OR=0.350, 95%CI 0.165 to 0.743, P=0.005). In addition, there was no statistically significant difference in the frequencies of mutant allele and genotypes of OPG (rs3102735) among subtypes of CD with different features (all P>0.012 5). Moreover, the DcR1 (rs12549481), DcR2 (rs1133782) and OPG (rs3102735) polymorphisms were not correlated with the efficacy of corticosteroid and infliximab (all P>0.05). \u0000 \u0000 \u0000Conclusions \u0000DcR1 (rs12549481) mutation may be correlated with stricturing CD. DcR2 (rs1133782) mutation may be corre","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"42 1","pages":"24-30"},"PeriodicalIF":0.0,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86589859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical analysis of different treatment options for cholecysto-choledocholithiasis 胆囊-胆总管结石不同治疗方案的临床分析
Pub Date : 2019-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2019.01.009
Ping Chen, Bingzhong Su, Chunli Cong, Hongxia Wang, Tong-ling Zhang, Jianjun Ren, Qi Wang, Xudong Liu
Objective To evaluate the efficacy of different treatment options for cholecysto-choledocholithiasis (CCL), and try to find the ideal treatment. Methods From January 2006 to January 2016, a total of 3 107 patients with CCL from the Affiliated Hospital of Inner Mongolia Medical University were enrolled. Among them, 1 283 patients were in open cholecystectomy (OC) and open common bile duct exploration (OCBDE) group, 964 patients were in laparoscopic cholecystectomy (LC) and laparoscopic common bile duct exploration (LCBDE) group, and 860 patients were in endoscopic retrograde cholangiopancreatography (ERCP)+ LC group. The clinical data of the three groups were analysed. One-way analysis of variance and chi-square test were performed for statistical analysis. Results From 2006 to 2010, the percentage of patients treated with OC+ OCBDE, LC+ LCBDE, and ERCP+ LC were 56.05%(829/1 479), 25.15%(372/1 479) and 18.80%(278/1 479), respectively; from 2011 to 2016, the percentage of patients received the above three treatments were 27.89%(454/1 628), 36.36%(592/1 628) and 35.75%(582/1 628), respectively. The difference in the proportion of the same treatment at different times was statistically significant (χ2=4.775, 4.168 and 0.669, all P 0.05). The hospital stay of the OC+ OCBDE group, the LC+ LCBDE group and the ERCP+ LC group were (6.7±1.3) days, (5.6±1.2) days and (10.9±1.6) days, respectively, and the differences were statistically significant (F=90.010, P<0.01). The hospitalization expenses of OC+ OCBDE group, LC+ LCBDE group and ERCP+ LC group were (13 720±1 910) yuan, (18 150±1 490) yuan and (25 830±2 430) yuan, respectively, and the differences were statistically significant (F=302.991, P<0.01). Conclusion The first choice of patients with CCL is endoscopic minimally invasive treatment and open surgery can be used as a remedial method for endoscopic treatment. Key words: Cholecysto-choledocholithiasis; Endoscopic minimally invasive treatment; Open surgery
目的评价不同治疗方案治疗胆囊胆总管结石的疗效,寻求理想的治疗方案。方法选取2006年1月~ 2016年1月内蒙古医科大学附属医院CCL患者3 107例。其中,开放胆囊切除术(OC) +开放胆总管探查(OCBDE)组1 283例,腹腔镜胆囊切除术(LC) +腹腔镜胆总管探查(LCBDE)组964例,内镜逆行胰胆管造影(ERCP)+ LC组860例。分析三组患者的临床资料。统计学分析采用单因素方差分析和卡方检验。结果2006 - 2010年,OC+ OCBDE、LC+ LCBDE和ERCP+ LC治疗的患者比例分别为56.05%(829/1 479)、25.15%(372/1 479)和18.80%(278/1 479);2011 - 2016年,接受上述三种治疗的患者比例分别为27.89%(454/1 628)、36.36%(592/1 628)和35.75%(582/1 628)。不同时间相同治疗比例差异有统计学意义(χ2=4.775、4.168、0.669,P均为0.05)。OC+ OCBDE组、LC+ LCBDE组和ERCP+ LC组住院时间分别为(6.7±1.3)d、(5.6±1.2)d和(10.9±1.6)d,差异有统计学意义(F=90.010, P<0.01)。OC+ OCBDE组、LC+ LCBDE组、ERCP+ LC组住院费用分别为(13 720±1 910)元、(18 150±1 490)元、(25 830±2 430)元,差异有统计学意义(F=302.991, P<0.01)。结论内镜下微创治疗是CCL患者的首选,开放手术可作为内镜下治疗的一种补救方法。关键词:胆囊胆总管结石;内镜微创治疗;开放手术
{"title":"Clinical analysis of different treatment options for cholecysto-choledocholithiasis","authors":"Ping Chen, Bingzhong Su, Chunli Cong, Hongxia Wang, Tong-ling Zhang, Jianjun Ren, Qi Wang, Xudong Liu","doi":"10.3760/CMA.J.ISSN.0254-1432.2019.01.009","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2019.01.009","url":null,"abstract":"Objective \u0000To evaluate the efficacy of different treatment options for cholecysto-choledocholithiasis (CCL), and try to find the ideal treatment. \u0000 \u0000 \u0000Methods \u0000From January 2006 to January 2016, a total of 3 107 patients with CCL from the Affiliated Hospital of Inner Mongolia Medical University were enrolled. Among them, 1 283 patients were in open cholecystectomy (OC) and open common bile duct exploration (OCBDE) group, 964 patients were in laparoscopic cholecystectomy (LC) and laparoscopic common bile duct exploration (LCBDE) group, and 860 patients were in endoscopic retrograde cholangiopancreatography (ERCP)+ LC group. The clinical data of the three groups were analysed. One-way analysis of variance and chi-square test were performed for statistical analysis. \u0000 \u0000 \u0000Results \u0000From 2006 to 2010, the percentage of patients treated with OC+ OCBDE, LC+ LCBDE, and ERCP+ LC were 56.05%(829/1 479), 25.15%(372/1 479) and 18.80%(278/1 479), respectively; from 2011 to 2016, the percentage of patients received the above three treatments were 27.89%(454/1 628), 36.36%(592/1 628) and 35.75%(582/1 628), respectively. The difference in the proportion of the same treatment at different times was statistically significant (χ2=4.775, 4.168 and 0.669, all P 0.05). The hospital stay of the OC+ OCBDE group, the LC+ LCBDE group and the ERCP+ LC group were (6.7±1.3) days, (5.6±1.2) days and (10.9±1.6) days, respectively, and the differences were statistically significant (F=90.010, P<0.01). The hospitalization expenses of OC+ OCBDE group, LC+ LCBDE group and ERCP+ LC group were (13 720±1 910) yuan, (18 150±1 490) yuan and (25 830±2 430) yuan, respectively, and the differences were statistically significant (F=302.991, P<0.01). \u0000 \u0000 \u0000Conclusion \u0000The first choice of patients with CCL is endoscopic minimally invasive treatment and open surgery can be used as a remedial method for endoscopic treatment. \u0000 \u0000 \u0000Key words: \u0000Cholecysto-choledocholithiasis; Endoscopic minimally invasive treatment; Open surgery","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"79 1","pages":"40-44"},"PeriodicalIF":0.0,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75155157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum metabonomics study in 66 patients with gastric cancer by liquid chromatography-mass spectrometry 液相色谱-质谱联用法研究66例胃癌患者血清代谢组学
Pub Date : 2019-01-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2019.01.004
Ge Li, Xiaomi Li, Huiming Lu
Objective To detect whether patients with gastric cancer had unique serum metabolomic characteristics by liquid chromatography-mass spectrometry (LC-MS) metabolomic analysis, and to screen potential markers for early gastric cancer and to preliminarily explore the related metabolic pathways. Methods At the First Affiliated Hospital of Soochow University, 66 patients with gastric cancer and 44 patients with benign gastric disease from July, 2017 to January, 2018 were enrolled, and 50 healthy subjects served as controls. Twenty-five patients with gastric cancer at stage Ⅰ and Ⅱ and 25 patients with gastric cancer at stage Ⅲ and Ⅳ were selected from the 66 patients with gastric cancer, and 25 subjects were also selected from 50 healthy controls. The plasma small molecule metabolites of patients with gastric cancer and benign gastric disease and healthy controls were detected by LC-MS method. Multivariate logistic regression analysis was used to establish and validate the principal component analysis (PCA) model and partial least squares-discriminant analysis (PLS-DA) model and screen the differential metabolites. The receiver operating characteristic curve analysis was used to evaluated the clinical efficacy of differential metabolites. Results PCA and PLS-DA models showed that gastric cancer had a obviously specific metabolites profile, the profile of benign gastric disease overlapped with that of gastric cancer and healthy controls. The results of multivariate logistic regression analysis confirmed that four metabolites including isoleucine, benzophenone, sphingosine-1-phosphate and galactopyranose set could be used to establish an optimal diagnostic model. The area under the curve (AUC) (95% confidence interval (CI)) was 0.963 (0.930 to 0.997), and the best cut off value, sensitivity and specificity were 0.871, 93.1% and 94.0%, respectively. Meanwhile, patients with gastric cancer at stage Ⅰ+ Ⅱ and stage Ⅲ+ Ⅳ had a distinct clustering trend compared with the control group. In the serum of patients with gastric cancer at stage Ⅰ+ Ⅱ and stage Ⅲ+ Ⅳ, a total of 24 differential metabolites were identified, the concentration of five of which including lysine, carnitine, benzenesulfonamide, arginine and docosahexaenoic acid ethyl ester, increased along with the progression of gastric cancer. Pipecolic acid and kynurenine might served as biomarkers for early and mid gastric cancer (stage Ⅰ+ Ⅱ) screening. Conclusions LC-MS metabolomic effectively confirm the unique changes of serum metabolites in patients with gastric cancer. The screened differential metabolites have potential clinical application value for predicting the risk of gastric cancer. Key words: Stomach neoplasms; Metabolism; Biological markers; Liquid chromatography-mass spectrometer
目的通过液相色谱-质谱(LC-MS)代谢组学分析,检测胃癌患者是否具有独特的血清代谢组学特征,筛选早期胃癌的潜在标志物,并初步探讨相关代谢途径。方法选取2017年7月至2018年1月苏州大学第一附属医院的66例胃癌患者和44例良性胃疾病患者,并以50名健康受试者为对照。从66例胃癌患者中选取25例Ⅰ、Ⅱ期胃癌患者和25例Ⅲ、Ⅳ期胃癌患者,从50例健康对照中选取25例受试者。采用LC-MS法检测胃癌、胃良性疾病患者及健康对照者血浆小分子代谢物。采用多元logistic回归分析建立并验证主成分分析(PCA)模型和偏最小二乘判别分析(PLS-DA)模型,筛选差异代谢物。采用受试者工作特征曲线分析评价差异代谢物的临床疗效。结果PCA和PLS-DA模型显示,胃癌具有明显的特异性代谢物谱,良性胃疾病的代谢物谱与胃癌和健康对照组的代谢物谱重叠。多因素logistic回归分析结果证实,异亮氨酸、二苯甲酮、鞘氨醇-1-磷酸和半乳糖ranose四种代谢物可用于建立最优诊断模型。曲线下面积(AUC)(95%可信区间(CI)为0.963(0.930 ~ 0.997),最佳截断值为0.871,灵敏度为93.1%,特异度为94.0%。同时,与对照组相比,Ⅰ+Ⅱ和Ⅲ+Ⅳ期胃癌患者有明显的聚类趋势。在Ⅰ+Ⅱ期和Ⅲ+Ⅳ期胃癌患者的血清中,共鉴定出24种差异代谢物,其中赖氨酸、肉碱、苯磺酰胺、精氨酸和二十二碳六烯酸乙酯等5种代谢物的浓度随着胃癌的进展而升高。细果酸和犬尿氨酸可能作为早期和中期胃癌(Ⅰ+Ⅱ期)筛查的生物标志物。结论LC-MS代谢组学有效地证实了胃癌患者血清代谢物的独特变化。筛选的差异代谢物在预测胃癌发生风险方面具有潜在的临床应用价值。关键词:胃肿瘤;新陈代谢;生物标志物;液相色谱-质谱仪
{"title":"Serum metabonomics study in 66 patients with gastric cancer by liquid chromatography-mass spectrometry","authors":"Ge Li, Xiaomi Li, Huiming Lu","doi":"10.3760/CMA.J.ISSN.0254-1432.2019.01.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2019.01.004","url":null,"abstract":"Objective \u0000To detect whether patients with gastric cancer had unique serum metabolomic characteristics by liquid chromatography-mass spectrometry (LC-MS) metabolomic analysis, and to screen potential markers for early gastric cancer and to preliminarily explore the related metabolic pathways. \u0000 \u0000 \u0000Methods \u0000At the First Affiliated Hospital of Soochow University, 66 patients with gastric cancer and 44 patients with benign gastric disease from July, 2017 to January, 2018 were enrolled, and 50 healthy subjects served as controls. Twenty-five patients with gastric cancer at stage Ⅰ and Ⅱ and 25 patients with gastric cancer at stage Ⅲ and Ⅳ were selected from the 66 patients with gastric cancer, and 25 subjects were also selected from 50 healthy controls. The plasma small molecule metabolites of patients with gastric cancer and benign gastric disease and healthy controls were detected by LC-MS method. Multivariate logistic regression analysis was used to establish and validate the principal component analysis (PCA) model and partial least squares-discriminant analysis (PLS-DA) model and screen the differential metabolites. The receiver operating characteristic curve analysis was used to evaluated the clinical efficacy of differential metabolites. \u0000 \u0000 \u0000Results \u0000PCA and PLS-DA models showed that gastric cancer had a obviously specific metabolites profile, the profile of benign gastric disease overlapped with that of gastric cancer and healthy controls. The results of multivariate logistic regression analysis confirmed that four metabolites including isoleucine, benzophenone, sphingosine-1-phosphate and galactopyranose set could be used to establish an optimal diagnostic model. The area under the curve (AUC) (95% confidence interval (CI)) was 0.963 (0.930 to 0.997), and the best cut off value, sensitivity and specificity were 0.871, 93.1% and 94.0%, respectively. Meanwhile, patients with gastric cancer at stage Ⅰ+ Ⅱ and stage Ⅲ+ Ⅳ had a distinct clustering trend compared with the control group. In the serum of patients with gastric cancer at stage Ⅰ+ Ⅱ and stage Ⅲ+ Ⅳ, a total of 24 differential metabolites were identified, the concentration of five of which including lysine, carnitine, benzenesulfonamide, arginine and docosahexaenoic acid ethyl ester, increased along with the progression of gastric cancer. Pipecolic acid and kynurenine might served as biomarkers for early and mid gastric cancer (stage Ⅰ+ Ⅱ) screening. \u0000 \u0000 \u0000Conclusions \u0000LC-MS metabolomic effectively confirm the unique changes of serum metabolites in patients with gastric cancer. The screened differential metabolites have potential clinical application value for predicting the risk of gastric cancer. \u0000 \u0000 \u0000Key words: \u0000Stomach neoplasms; Metabolism; Biological markers; Liquid chromatography-mass spectrometer","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"32 1","pages":"12-18"},"PeriodicalIF":0.0,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86036912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the clinicopathological features between synchronous multiple early gastric cancer and single early gastric cancer 同步多发早期胃癌与单发早期胃癌的临床病理特征比较
Pub Date : 2018-12-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2018.12.004
Guangxia Chen, Chuannan Wu, Haihan Zhang, Li-yong Gao, Jin Ding, Liu Shiyu
Objective To investigate the clinicopathological features and correlation between synchronous multiple early gastric cancer(SMEGC)and single early gastric cancer (EGC). Methods From January 2008 to December 2016, the clinical data of 994 patients with EGC who underwent open or laparoscopic gastrectomy surgery were collected from the electronic medical data base of the First Affiliated Hospital of Nanjing Medical University and Xuzhou No.1 People′s Hospital. The data of patients including gender, age, tumor morphologys, tumor location, tumor size, histological type, depth of invasion, lymph nodes metastasis, lymphovascular metastasis, peripheral nerve invasion, and blood types were analyzed. T test and Chi square test were used for statistical analysis. Results Among 994 EGC patients, 27 cases (2.7%) were SMEGC, and 967 cases (97.3%) were single EGC. The percentage of male and female of single EGC were 71.4% (690/967) and 28.6% (277/967), respectively; the percentage of male and female of SMEGC were 88.9% (24/27) and 11.1%(3/27), respectively, and there was statistically significant difference in the gender composition ratio between single EGC and SMEGC (χ2=3.975, P=0.046). The incidence of ulcer in single EGC and SMEGC were 50.6% (489/967) and 29.6% (8/27), respectively, and the difference in the incidence of ulcers between single EGC and SMEGC was statistically significant (χ2=4.653, P=0.031). There were no statistically significant differences between single EGC and SMEGC in gross morphology, depth of invasion, lymph nodes metastasis, lymphovascular metastasis, peripheral nerve invasion, tumor location, pathological type and blood types (all P>0.05). In the SMEGC patients, the incidence of main lesions invading the mucosa was 48.1% (13/27) and submucosa invasion was 51.9% (14/27); and for minor lesions, the corresponding incidences were 77.8% (21/27) and 22.2% (6/27), respectively, and the difference was statistically significant (χ2=5.063, P 0.05). Conclusions The main risk factors of SMEGC are male and no ulcerative lesions. The clinicopathological features are similar between main lesions and minor lesions in SMEGC. Key words: Synchronous multiple early gastric cancer; Main lesions; Minor lesions; Clinicopathological features
目的探讨同步多发早期胃癌(SMEGC)与单发早期胃癌(EGC)的临床病理特征及相关性。方法收集2008年1月至2016年12月南京医科大学第一附属医院和徐州市第一人民医院电子医疗数据库中994例行开放式或腹腔镜胃切除术的EGC患者的临床资料。分析患者的性别、年龄、肿瘤形态、肿瘤位置、肿瘤大小、组织学类型、浸润深度、淋巴结转移、淋巴血管转移、周围神经侵犯、血型等资料。采用T检验和卡方检验进行统计分析。结果994例EGC中,单纯性EGC 27例(2.7%),单纯性EGC 967例(97.3%)。单次EGC男、女分别占71.4%(690/967)和28.6% (277/967);单个EGC与SMEGC的性别构成比差异有统计学意义(χ2=3.975, P=0.046),其中男性占88.9%(24/27),女性占11.1%(3/27)。单发EGC与SMEGC的溃疡发生率分别为50.6%(489/967)、29.6%(8/27),单发EGC与SMEGC的溃疡发生率差异有统计学意义(χ2=4.653, P=0.031)。单个EGC与SMEGC在大体形态、浸润深度、淋巴结转移、淋巴血管转移、周围神经侵犯、肿瘤位置、病理分型、血型等方面差异均无统计学意义(P < 0.05)。SMEGC患者主要病变侵袭粘膜的发生率为48.1%(13/27),粘膜下层病变侵袭率为51.9% (14/27);轻微病变发生率分别为77.8%(21/27)、22.2%(6/27),差异有统计学意义(χ2=5.063, p0.05)。结论SMEGC的主要危险因素为男性,无溃疡性病变。SMEGC的主要病变和次要病变的临床病理特征相似。关键词:同步多发早期胃癌;主要病变;微小病变;临床病理特征
{"title":"Comparison of the clinicopathological features between synchronous multiple early gastric cancer and single early gastric cancer","authors":"Guangxia Chen, Chuannan Wu, Haihan Zhang, Li-yong Gao, Jin Ding, Liu Shiyu","doi":"10.3760/CMA.J.ISSN.0254-1432.2018.12.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2018.12.004","url":null,"abstract":"Objective \u0000To investigate the clinicopathological features and correlation between synchronous multiple early gastric cancer(SMEGC)and single early gastric cancer (EGC). \u0000 \u0000 \u0000Methods \u0000From January 2008 to December 2016, the clinical data of 994 patients with EGC who underwent open or laparoscopic gastrectomy surgery were collected from the electronic medical data base of the First Affiliated Hospital of Nanjing Medical University and Xuzhou No.1 People′s Hospital. The data of patients including gender, age, tumor morphologys, tumor location, tumor size, histological type, depth of invasion, lymph nodes metastasis, lymphovascular metastasis, peripheral nerve invasion, and blood types were analyzed. T test and Chi square test were used for statistical analysis. \u0000 \u0000 \u0000Results \u0000Among 994 EGC patients, 27 cases (2.7%) were SMEGC, and 967 cases (97.3%) were single EGC. The percentage of male and female of single EGC were 71.4% (690/967) and 28.6% (277/967), respectively; the percentage of male and female of SMEGC were 88.9% (24/27) and 11.1%(3/27), respectively, and there was statistically significant difference in the gender composition ratio between single EGC and SMEGC (χ2=3.975, P=0.046). The incidence of ulcer in single EGC and SMEGC were 50.6% (489/967) and 29.6% (8/27), respectively, and the difference in the incidence of ulcers between single EGC and SMEGC was statistically significant (χ2=4.653, P=0.031). There were no statistically significant differences between single EGC and SMEGC in gross morphology, depth of invasion, lymph nodes metastasis, lymphovascular metastasis, peripheral nerve invasion, tumor location, pathological type and blood types (all P>0.05). In the SMEGC patients, the incidence of main lesions invading the mucosa was 48.1% (13/27) and submucosa invasion was 51.9% (14/27); and for minor lesions, the corresponding incidences were 77.8% (21/27) and 22.2% (6/27), respectively, and the difference was statistically significant (χ2=5.063, P 0.05). \u0000 \u0000 \u0000Conclusions \u0000The main risk factors of SMEGC are male and no ulcerative lesions. The clinicopathological features are similar between main lesions and minor lesions in SMEGC. \u0000 \u0000 \u0000Key words: \u0000Synchronous multiple early gastric cancer; Main lesions; Minor lesions; Clinicopathological features","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"135 44","pages":"806-810"},"PeriodicalIF":0.0,"publicationDate":"2018-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72558932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A prospective cohort study on triglycerides levels and risk of acute pancreatitis 甘油三酯水平与急性胰腺炎风险的前瞻性队列研究
Pub Date : 2018-12-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2018.12.008
G. Zhu, Bing Zhang, R. Ji, Q. Sun, Yanmin Zhang, Haitao Wang, Shan Wang, B. Tong, Hailing Zhang, Qian Wang, Jiejing Zhang, Xiaozhong Jiang, Shuohua Chen, Xi Men
Objective To investigate the effects of fasting serum triglycerides (TG) levels at different baseline on the risk of new-onset acute pancreatitis (AP) in in-service and retired employees of Kailuan Group. Methods A total of 125 178 in-service and retired employees of Kailuan Group who received health check-ups from 2006 to 2009 and had no AP history but had complete TG data were prospectively enrolled. According to quantile level, the baseline serum fasting TG level of study subjects were divided into 1.64 mmol/L group (n=41 339). The incidence of new-onset AP of these three groups was analyzed. The survival curve was plotted by Kaplan-Meier method. The cumulative incidence rate was calculated and tested by log-rank method. And multivariate Cox proportional hazards regression model was performed to calculate hazard ratios (HR) of baseline fasting serum TG level for AP. Results After followed up for (7.36±1.23) years, a total of 193 cases of AP occurred. The incidences of AP in 1.64 mmol/L group were 1.43 events/10 000 person-years, 2.37 events/10 000 person-years and 2.49 events/10 000 person-years, respectively. The cumulative incidence rates of AP in 1.64 mmol/L group were 0.10% (44/42 128), 0.18% (73/41 711) and 0.18% (76/41 339), respectively, and the difference was statistically significant (χ2=9.998, P=0.007). The results of multivariate Cox proportional hazards regression model analysis indicated that the risk of AP increased in 1.01 to 1.64 mmol/L group and >1.64 mmol/L group compared with that of 1.64 mmol/L group were 1.70 (1.11 to 2.58) and 1.69 (1.10 to 2.60), respectively. Conclusion Baseline fasting serum TG levels over 1.01 mmol/L may increase the risk of AP. Key words: Triglycerides; Cohort studies; Acute pancreatitis
目的探讨不同基线下空腹血清甘油三酯(TG)水平对开滦集团在职和退休员工新发急性胰腺炎(AP)发病风险的影响。方法对2006 ~ 2009年接受健康体检的开滦集团在职和退休员工125 178名,无AP病史但TG数据完整。根据分位数水平,将研究对象空腹血清TG基线水平分为1.64 mmol/L组(n=41 339)。分析三组患者新发AP的发生率。用Kaplan-Meier法绘制生存曲线。累积发病率采用log-rank法计算和检验。采用多因素Cox比例风险回归模型计算AP基线空腹血清TG水平的风险比(HR)。结果随访(7.36±1.23)年,共发生AP 193例。1.64 mmol/L组AP发病率分别为1.43例/ 10000人-年、2.37例/ 10000人-年和2.49例/ 10000人-年。1.64 mmol/L组AP累计发病率分别为0.10%(44/42 128)、0.18%(73/41 711)、0.18%(76/41 339),差异有统计学意义(χ2=9.998, P=0.007)。多因素Cox比例风险回归模型分析结果显示,与1.64 mmol/L组相比,1.01 ~ 1.64 mmol/L组和>1.64 mmol/L组AP风险分别为1.70(1.11 ~ 2.58)和1.69(1.10 ~ 2.60)。结论基线空腹血清TG水平超过1.01 mmol/L可增加AP发生风险。关键词:甘油三酯;队列研究;急性胰腺炎
{"title":"A prospective cohort study on triglycerides levels and risk of acute pancreatitis","authors":"G. Zhu, Bing Zhang, R. Ji, Q. Sun, Yanmin Zhang, Haitao Wang, Shan Wang, B. Tong, Hailing Zhang, Qian Wang, Jiejing Zhang, Xiaozhong Jiang, Shuohua Chen, Xi Men","doi":"10.3760/CMA.J.ISSN.0254-1432.2018.12.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2018.12.008","url":null,"abstract":"Objective \u0000To investigate the effects of fasting serum triglycerides (TG) levels at different baseline on the risk of new-onset acute pancreatitis (AP) in in-service and retired employees of Kailuan Group. \u0000 \u0000 \u0000Methods \u0000A total of 125 178 in-service and retired employees of Kailuan Group who received health check-ups from 2006 to 2009 and had no AP history but had complete TG data were prospectively enrolled. According to quantile level, the baseline serum fasting TG level of study subjects were divided into 1.64 mmol/L group (n=41 339). The incidence of new-onset AP of these three groups was analyzed. The survival curve was plotted by Kaplan-Meier method. The cumulative incidence rate was calculated and tested by log-rank method. And multivariate Cox proportional hazards regression model was performed to calculate hazard ratios (HR) of baseline fasting serum TG level for AP. \u0000 \u0000 \u0000Results \u0000After followed up for (7.36±1.23) years, a total of 193 cases of AP occurred. The incidences of AP in 1.64 mmol/L group were 1.43 events/10 000 person-years, 2.37 events/10 000 person-years and 2.49 events/10 000 person-years, respectively. The cumulative incidence rates of AP in 1.64 mmol/L group were 0.10% (44/42 128), 0.18% (73/41 711) and 0.18% (76/41 339), respectively, and the difference was statistically significant (χ2=9.998, P=0.007). The results of multivariate Cox proportional hazards regression model analysis indicated that the risk of AP increased in 1.01 to 1.64 mmol/L group and >1.64 mmol/L group compared with that of 1.64 mmol/L group were 1.70 (1.11 to 2.58) and 1.69 (1.10 to 2.60), respectively. \u0000 \u0000 \u0000Conclusion \u0000Baseline fasting serum TG levels over 1.01 mmol/L may increase the risk of AP. \u0000 \u0000 \u0000Key words: \u0000Triglycerides; Cohort studies; Acute pancreatitis","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"122 1","pages":"829-834"},"PeriodicalIF":0.0,"publicationDate":"2018-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77939010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华消化杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1